Sign in

CIK 0001806952

  • Non-accelerated filer
  • Smaller reporting company

Lyell Immunopharma, Inc.

Sign in to watch
Ticker
LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833006753
Phone
+1 650-695-0677
Business address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$49,999,983
in 2 filings
Open-market sales, last 90 days
$215,781
in 9 filings

Net +$49,784,202. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 41 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-09 Shook David Chief Medical Officer Grant or award +21,900 21,900
2025-06-09 Shook David Chief Medical Officer Grant or award · Option (right to buy) +43,750 43,750
2025-05-15 Klausner Richard Director Grant or award · Option (right to buy) +130,000 130,000
2025-05-15 RIEFLIN WILLIAM JL Director Grant or award · Option (right to buy) +130,000 130,000
2025-05-15 FRIEDMAN CATHY Director Grant or award · Option (right to buy) +130,000 130,000
2025-05-15 BRAWLEY OTIS W Director Grant or award · Option (right to buy) +130,000 130,000
2025-05-15 NABEL ELIZABETH G Director Grant or award · Option (right to buy) +130,000 130,000
2025-05-15 Ramachandra Sumant Director Grant or award · Option (right to buy) +130,000 130,000
2025-03-31 BRAWLEY OTIS W Director Purchase +35,640 $0.56 $20K 35,640
2025-03-21 Ramachandra Sumant Director Purchase +200,000 $0.58 $115K 200,000
2025-03-17 Newton Charles W. Chief Financial Officer Purchase +200,000 $0.56 $112K 200,000
2025-03-14 Klausner Richard Director Purchase +158,000 $0.60 $95K 843,365
2025-03-14 Seely Lynn President and CEO Purchase +175,000 $0.61 $106K 712,500
2025-02-10 Lang Matthew Chief Business Officer Grant or award +112,500 162,500
2025-02-10 Lang Matthew Chief Business Officer Grant or award · Option (right to buy) +450,000 450,000
2025-02-10 Lang Matthew Chief Business Officer Grant or award · Option (right to buy) +56,250 56,250
2025-02-10 Seely Lynn President and CEO Grant or award +337,500 537,500
2025-02-10 Seely Lynn President and CEO Grant or award · Option (right to buy) +1,350,000 1,350,000
2025-02-10 Seely Lynn President and CEO Grant or award · Option (right to buy) +168,750 168,750
2025-02-10 Hill Stephen J. Chief Operating Officer Grant or award +112,500 172,899

Page 5 of 8 · 156 trades